Skip to main content
HairCited

Minoxidil untuk Alopecia Androgenetik

A

Berdasarkan 191 studi (19 meta-analyses, 21 RCTs) dengan 41,495 peserta secara total. 159/191 studi menunjukkan efek positif.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Kesimpulan

Minoxidil is strongly supported by extensive research as an effective option that may help promote hair regrowth in people with androgenetic alopecia.

  • 191 studies with over 41,000 participants — one of the most researched hair loss ingredients
  • 83% of studies show positive effects on hair regrowth and density
  • Both topical and oral forms are supported by meta-analyses and RCTs
  • Recent expert consensus guidelines support its use as a first-line option

Key Study Findings

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Efek: None None

Populasi: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Efek: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efek: None None

Populasi: women with androgenetic alopecia (female pattern hair loss)

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs: Placebo Efek: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Efek: None None

Key Statistics

299

Studi

68291

Peserta

Positive

A

Peringkat

Referenced Papers

Journal of the … 2026
Aesthetic plastic surgery 2025 14 sitasi
Anais brasileiros de … 2025 7 sitasi
Acta dermato-venereologica 2025 4 sitasi
European journal of … 2025 3 sitasi
Australian prescriber 2025 2 sitasi
Acta dermatovenerologica Alpina, … 2025 2 sitasi
Skin appendage disorders 2025 1 sitasi
Journal of clinical … 2025 1 sitasi
International journal of … 2025 1 sitasi
Annals of dermatology 2025
Nature reviews. Disease … 2025
Archives of dermatological … 2025
International journal of … 2024 39 sitasi
Indian journal of … 2024 14 sitasi
Journal of cosmetic … 2024 11 sitasi
Journal of clinical … 2024 10 sitasi
Photodermatology, photoimmunology & … 2024 8 sitasi
Facial plastic surgery … 2024 8 sitasi
American family physician 2024 8 sitasi
Skin health and … 2024 7 sitasi
International journal of … 2024 5 sitasi
SAGE open medical … 2024 3 sitasi
Vestnik oftalmologii 2024 1 sitasi
Drugs 2023 221 sitasi
JAAD international 2023 80 sitasi
Clinical, cosmetic and … 2023 58 sitasi
American journal of … 2023 41 sitasi
Anais brasileiros de … 2023 29 sitasi
Skin appendage disorders 2023 27 sitasi
Archives of dermatological … 2023 16 sitasi
Journal der Deutschen … 2023 5 sitasi
Journal of cosmetic … 2023 3 sitasi
BMJ case reports 2023 2 sitasi
Clinics in plastic … 2023 1 sitasi
International journal of … 2023 1 sitasi
The Journal of … 2022 170 sitasi
Faculty reviews 2022 44 sitasi
Dermatologic therapy 2022 41 sitasi
Journal of cosmetic … 2022 35 sitasi
Journal of cosmetic … 2022 7 sitasi
Cureus 2022 3 sitasi
Facial plastic surgery … 2022
Journal of cutaneous … 2021 44 sitasi
Journal of the … 2021 42 sitasi
Actas dermo-sifiliograficas 2021 3 sitasi
Expert opinion on … 2020 147 sitasi
American journal of … 2020 127 sitasi
International journal of … 2020 58 sitasi
Indian dermatology online … 2020 31 sitasi
Dermatologic clinics 2020 15 sitasi
Facial plastic surgery … 2020 15 sitasi
Alternative therapies in … 2020 11 sitasi
Drug design, development … 2019 320 sitasi
Journal of cosmetic … 2019 100 sitasi
American journal of … 2019 84 sitasi
Expert opinion on … 2019 34 sitasi
Bioscience, biotechnology, and … 2019 9 sitasi
Journal of the … 2018 114 sitasi
Indian journal of … 2018 79 sitasi
Dermatologic therapy 2018 63 sitasi
Australian journal of … 2018 8 sitasi
American family physician 2017 141 sitasi
JAMA dermatology 2017 121 sitasi
Current clinical pharmacology 2017 62 sitasi
Actas dermo-sifiliograficas 2017 17 sitasi
BMJ case reports 2017 6 sitasi
Deutsches Arzteblatt international 2016 99 sitasi
The Cochrane database … 2016 18 sitasi
Current problems in … 2015 8 sitasi
Der Internist 2015
Expert opinion on … 2014 57 sitasi
Skin therapy letter 2014 29 sitasi
Giornale italiano di … 2014 8 sitasi
Giornale italiano di … 2014
Indian journal of … 2013 196 sitasi
Dermatologic clinics 2013 78 sitasi
Journal of cosmetic … 2013 62 sitasi
International journal of … 2013 61 sitasi
Facial plastic surgery … 2013 16 sitasi
Indian journal of … 2013 16 sitasi
International journal of … 2013
The Cochrane database … 2012 15 sitasi
Expert opinion on … 2010 264 sitasi
Current opinion in … 2009 54 sitasi
Seminars in cutaneous … 2009 4 sitasi
American family physician 2009
Current opinion in … 2008 31 sitasi
Nihon rinsho. Japanese … 2008 6 sitasi
Endocrinology and metabolism … 2007 33 sitasi
Clinical interventions in … 2007
Acta dermatovenerologica Alpina, … 2005
Annual review of … 2004 664 sitasi
Revue medicale de … 2004
The journal of … 2003 102 sitasi
Praxis 2003 28 sitasi
American family physician 2003 2 sitasi
American family physician 2003
Clinical and experimental … 2002 61 sitasi
Therapeutische Umschau. Revue … 2002 4 sitasi
American journal of … 2000 18 sitasi
Southern medical journal 2000
International journal of … 1999 16 sitasi
International journal of … 1999
American family physician 1999
Journal of the … 1999
Journal of cutaneous … 1999
Dermatologic clinics 1998 121 sitasi
Annales de dermatologie … 1997
Journal of the … 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

topical:
2-5% solution, twice daily

Batas atas: 5% topical solution

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Neutral --
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
None -- Positive --
None -- Positive --
None -- Positive 11
not specified -- Positive --

Waktu terbaik diminum: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interaksi yang Diketahui

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Asupan atas yang dapat ditoleransi: 5% topical solution

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Minoxidil help with Alopecia Androgenetik?
Based on 299 studies with 68,291 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia Androgenetik management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia Androgenetik?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia Androgenetik?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 299 peer-reviewed studies with 68,291 total participants. The overall direction of effect is positive.

Related Evidence

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.